Reducing the risk of percutaneous intervention after coronary bypass surgery: Beneficial effects of abciximab treatment
Publication
, Journal Article
Tcheng, JE; Anderson, K; Tardiff, BE; Cabot, CF; Lincoff, AM; Califf, RM; Topol, EJ
Published in: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
February 1, 1997
Duke Scholars
Published In
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
ISSN
0735-1097
Publication Date
February 1, 1997
Volume
29
Issue
2
Start / End Page
7395 / 7395
Publisher
ELSEVIER SCIENCE INC
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Tcheng, J. E., Anderson, K., Tardiff, B. E., Cabot, C. F., Lincoff, A. M., Califf, R. M., & Topol, E. J. (1997). Reducing the risk of percutaneous intervention after coronary bypass surgery: Beneficial effects of abciximab treatment. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 29(2), 7395–7395.
Tcheng, J. E., K. Anderson, B. E. Tardiff, C. F. Cabot, A. M. Lincoff, R. M. Califf, and E. J. Topol. “Reducing the risk of percutaneous intervention after coronary bypass surgery: Beneficial effects of abciximab treatment.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 29, no. 2 (February 1, 1997): 7395–7395.
Tcheng JE, Anderson K, Tardiff BE, Cabot CF, Lincoff AM, Califf RM, et al. Reducing the risk of percutaneous intervention after coronary bypass surgery: Beneficial effects of abciximab treatment. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 1997 Feb 1;29(2):7395–7395.
Tcheng, J. E., et al. “Reducing the risk of percutaneous intervention after coronary bypass surgery: Beneficial effects of abciximab treatment.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 29, no. 2, ELSEVIER SCIENCE INC, Feb. 1997, pp. 7395–7395.
Tcheng JE, Anderson K, Tardiff BE, Cabot CF, Lincoff AM, Califf RM, Topol EJ. Reducing the risk of percutaneous intervention after coronary bypass surgery: Beneficial effects of abciximab treatment. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 1997 Feb 1;29(2):7395–7395.
Published In
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
ISSN
0735-1097
Publication Date
February 1, 1997
Volume
29
Issue
2
Start / End Page
7395 / 7395
Publisher
ELSEVIER SCIENCE INC
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology